Literature DB >> 10944235

Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse.

J Reese1, B C Paria, N Brown, X Zhao, J D Morrow, S K Dey.   

Abstract

Cyclooxygenase (COX)-derived prostaglandins (PGs) regulate numerous maternal-fetal interactions during pregnancy. PGs stimulate uterine contractions and prepare the cervix for parturition, whereas in the fetus, PGs maintain patency of the ductus arteriosus (DA), a vascular shunt that transmits oxygenated placental blood to the fetal systemic circulation. However, the origin and site of action of these PGs remain undefined. To address this, we analyzed mice lacking COX-1 (null mutation) or COX-2 (pharmacologic inhibition) or pups with a double null mutation. Our results show that COX-1 in the uterine epithelium is the major source of PGs during labor and that COX-1(-/-) females experience parturition failure that is reversible by exogenous PGs. Using embryo transfer experiments, we also show that successful delivery occurs in COX-1(-/-) recipient mothers carrying wild-type pups, establishing the sufficiency of fetal PGs for parturition. Although patency of the DA is PG dependent, neither COX-1 nor COX-2 expression was detected in the fetal or postnatal DA, and offspring with a double null mutation died shortly after birth with open DAs. These results suggest that DA patency depends on circulating PGs acting on specific PG receptors within the DA. Collectively, these findings demonstrate the coordinated regulation of fetal and maternal PGs at the time of birth but raise concern regarding the use of selective COX inhibitors for the management of preterm labor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944235      PMCID: PMC16938          DOI: 10.1073/pnas.97.17.9759

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice.

Authors:  E Segi; Y Sugimoto; A Yamasaki; Y Aze; H Oida; T Nishimura; T Murata; T Matsuoka; F Ushikubi; M Hirose; T Tanaka; N Yoshida; S Narumiya; A Ichikawa
Journal:  Biochem Biophys Res Commun       Date:  1998-05-08       Impact factor: 3.575

2.  Uterine expression of prostaglandin H2 synthase in late pregnancy and during parturition in prostaglandin F receptor-deficient mice.

Authors:  K Tsuboi; Y Sugimoto; A Iwane; K Yamamoto; S Yamamoto; A Ichikawa
Journal:  Endocrinology       Date:  2000-01       Impact factor: 4.736

3.  Aspirin and indomethacin prolong parturition in rats: evidence that prostaglandins contribute to expulsion of fetus.

Authors:  J W Aiken
Journal:  Nature       Date:  1972-11-03       Impact factor: 49.962

4.  Studies on closure of the ductus arteriosus. XI. Ductal closure in utero by a prostaglandin synthetase inhibitor.

Authors:  G L Sharpe; B Thalme; K S Larsson
Journal:  Prostaglandins       Date:  1974-12-10

5.  Indomethacin block of normal onset of parturition in primates.

Authors:  M J Novy; M J Cook; L Manaugh
Journal:  Am J Obstet Gynecol       Date:  1974-02-01       Impact factor: 8.661

6.  Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta.

Authors:  H Lim; R A Gupta; W G Ma; B C Paria; D E Moller; J D Morrow; R N DuBois; J M Trzaskos; S K Dey
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

7.  Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic.

Authors:  L Peruzzi; B Gianoglio; M G Porcellini; R Coppo
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

8.  COX-2 compensation in the uterus of COX-1 deficient mice during the pre-implantation period.

Authors:  J Reese; N Brown; B C Paria; J Morrow; S K Dey
Journal:  Mol Cell Endocrinol       Date:  1999-04-25       Impact factor: 4.102

9.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

Authors:  R Langenbach; S G Morham; H F Tiano; C D Loftin; B I Ghanayem; P C Chulada; J F Mahler; C A Lee; E H Goulding; K D Kluckman; H S Kim; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

Review 10.  Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.

Authors:  C Hammerman
Journal:  Clin Perinatol       Date:  1995-06       Impact factor: 3.430

View more
  45 in total

1.  Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation.

Authors:  Yong I Cha; Seok-Hyung Kim; Diane Sepich; F Gregory Buchanan; Lilianna Solnica-Krezel; Raymond N DuBois
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

2.  Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.

Authors:  Haibin Wang; Huirong Xie; Xiaofei Sun; Philip J Kingsley; Lawrence J Marnett; Benjamin F Cravatt; Sudhansu K Dey
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-11-28       Impact factor: 3.072

3.  Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall.

Authors:  Jeff Reese; Patrick W O'Mara; Stanley D Poole; Naoko Brown; Chelsea Tolentino; Delrae M Eckman; Judy L Aschner
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-11-13       Impact factor: 3.072

4.  Ablation of conceptus PTGS2 expression does not alter early conceptus development and establishment of pregnancy in the pig†.

Authors:  Caroline A Pfeiffer; Ashley E Meyer; Kelsey E Brooks; Paula R Chen; Jessica Milano-Foster; Lee D Spate; Joshua A Benne; Raissa F Cecil; Melissa S Samuel; Lauren A Ciernia; Christine M Spinka; Michael F Smith; Kevin D Wells; Thomas E Spencer; Randall S Prather; Rodney D Geisert
Journal:  Biol Reprod       Date:  2020-02-14       Impact factor: 4.285

Review 5.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

6.  Drug discovery strategies for the identification of novel regulators of uterine contractility.

Authors:  Shajila Siricilla; Chisom C Iwueke; Jennifer L Herington
Journal:  Curr Opin Physiol       Date:  2019-10-23

7.  Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice.

Authors:  Hee-Yoon Chang; Joseph Locker; Run Lu; Victor L Schuster
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

8.  Resveratrol directly targets COX-2 to inhibit carcinogenesis.

Authors:  Tatyana A Zykova; Feng Zhu; Xiuhong Zhai; Wei-Ya Ma; Svetlana P Ermakova; Ki Won Lee; Ann M Bode; Zigang Dong
Journal:  Mol Carcinog       Date:  2008-10       Impact factor: 4.784

9.  Expression of COX-1 and COX-2 in the endometrium of cyclic, pregnant and in a model of pseudopregnant rats and their regulation by sex steroids.

Authors:  Isabelle St-Louis; Mohan Singh; Kevin Brasseur; Valérie Leblanc; Sophie Parent; Eric Asselin
Journal:  Reprod Biol Endocrinol       Date:  2010-08-24       Impact factor: 5.211

10.  Aminoglycoside-mediated relaxation of the ductus arteriosus in sepsis-associated PDA.

Authors:  Megan M Vucovich; Robert B Cotton; Elaine L Shelton; Jeremy A Goettel; Noah J Ehinger; Stanley D Poole; Naoko Brown; James L Wynn; Bibhash C Paria; James C Slaughter; Reese H Clark; Mario A Rojas; Jeff Reese
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.